FLKS Flex Pharma Inc.

-0.11  -16%
Previous Close 0.69
Open 0.66
Price To Book 1.46
Market Cap 10,573,842
Shares 18,069,476
Volume 931,168
Short Ratio
Av. Daily Volume 1,264,611

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial terminated - noted June 13, 2018.
FLX-787 - COMMEND US trial
Amyotrophic lateral sclerosis (ALS)
Phase 2 trial terminated - noted June 13, 2018.
Charcot-Marie-Tooth (CMT)
Phase 2 endpoints not met - October 2016. Announced January 24, 2017 that other indications will take priority over nocturnal leg cramps.
Nocturnal Leg Cramp
Phase 2 data released March 26, 2018 - 27% decrease in spasms.
FLX-787 (Aust)
Multiple Sclerosis

Latest News

  1. Flex Pharma shareholders OK reverse-merger after drug failure
  2. Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting
  3. Flex Pharma Announces Broker Authority to Vote on Certain Proposals
  4. Flex Pharma Falls After Salarius Pharma Merger Delay
  5. Flex Pharma Announces Overwhelming Support to Date for the Proposed Merger with Salarius Pharmaceuticals but More Votes are Needed to Complete the Merger
  6. Flex Pharma Announces that ISS and Glass Lewis Recommend Shareholders Vote “FOR” All Agenda Items relating to Flex’s Strategic Merger with Salarius Pharmaceuticals
  7. Flex Pharma: 1Q Earnings Snapshot
  8. Flex Pharma Reports First Quarter 2019 Financial Results
  9. FLKS ALERT: Monteverde & Associates PC Encourages Flex Pharma, Inc. Shareholders to Contact the Firm
  10. Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation
  11. Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results
  12. Houston oncology co. aims to grow after merger announcement
  13. SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flex Pharma, Inc. - FLKS
  14. Deal of the Week: Houston oncology co. to merge with struggling pharma co. in Boston
  15. Houston oncology co. to merge with Boston’s struggling Flex Pharma
  16. FLKS News: Flex Pharma Stock Rockets Higher on Salarius Merger
  17. Flex Pharma Finds A Lifeline In Merger With Oncology Biotech Salarius Pharma
  18. 4 Healthcare Stocks To Watch On Friday (1/4/19)
  19. Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer